id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-1082-0018,FDA,FDA-2020-N-1082,"Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assay Devices, Renamed to Hepatitis C Virus Antibody Tests",Rule,Final Rule,2021-11-22T05:00:00Z,2021,11,2021-11-22T05:00:00Z,,2021-11-22T15:48:14Z,2021-25374,0,0,0900006484e71277